The industry urgently needs to understand that its current approach to policy is almost pre-destined to deliver disappointment and poor outcomes. …
The choice is to be more defensive or continue to suffer bad outcomes
September 19, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Rare autoimmune diseases impose a $1.2 billion annual burden on Australians
August 20, 2026 - - Latest News -
Recce advances pivotal diabetic foot infection trial with active antibiotic comparator arm
August 20, 2026 - - Latest News -
New Zealand researchers honoured for work tackling superbugs and blood cancer
August 20, 2026 - - Latest News -
Novo Nordisk backs care for rural health professionals in southern NSW
August 19, 2026 - - Latest News -
Opportunity #3 - finally deliver on the repeated claims of patient-centricity
August 19, 2026 - - Latest News -
Departmental restructure formally splits medicines financing from pharmacy services
August 19, 2026 - - Latest News -
Wesfarmers Health evolves its loyalty program with new Pulse Rewards
August 19, 2026 -